Show simple item record

Show simple item record

 

Show simple item record

dc.description.abstractThe pharmaceutical industry in Africa faces many challenges. Facilities and production practices need to be upgraded to meet international standards. Large capital investments, highly specific expertise and specially trained workers, increased regulatory oversight, as well as an overall positive business environment, are all necessary for the industry to develop. There is evidence emerging from case studies suggesting that, although India, China and Brazil continue to be major producers and suppliers of cheaper medicines serving the needs of African markets, the pharmaceutical sectors in many African countries are transforming. Strong strategic interests are beginning to catalyze direct government support of local production, with an emphasis on the promotion of access to medicines, followed closely by industrial policy concerns. This study provides an overview of the state of pharmaceutical production in Africa and identifies challenges in the sector. Additionally, it assesses the coherence or/and inconsistencies of policy frameworks surrounding the pharmaceutical sector on the African continent, and recommends policies to increase the production and sustainability of the supply of medicines for improved health outcomes. Also, the study seeks to identify best practices that have supported the development of the pharmaceutical industry in Africa and other continents.en
dc.titleReview of policies and strategies for the pharmaceutical production sector in Africa: policy coherence, best practices and future prospectiveen
uneca.subject.fulltaxonomyUNBIS::INDUSTRY::CHEMICAL INDUSTRY AND PHARMACEUTICALS::PHARMACEUTICAL INDUSTRYen
uneca.subject.fulltaxonomyUNBIS::INDUSTRY::CHEMICAL INDUSTRY AND PHARMACEUTICALS::PHARMACEUTICAL CHEMISTRYen
uneca.subject.fulltaxonomyUNBIS::INDUSTRY::CHEMICAL INDUSTRY AND PHARMACEUTICALS::PHARMACEUTICALSen
uneca.creatorCorporate.fulltaxonomyCorporate Authors::United Nations. Economic Commission for Africaen
ags.creatorCorporateUnited Nations. Economic Commission for Africaen
ags.subjectThesaurusPHARMACEUTICAL INDUSTRYen
ags.subjectThesaurusPHARMACEUTICAL CHEMISTRYen
ags.subjectThesaurusPHARMACEUTICALSen
ags.descriptionNotesIncludes Annexes and bibliographical referenceen
ags.publisherPlaceAddis Ababaen
ags.publisherNameUN. ECAen
dc.date.accessioned2020-09-23T12:35:05Z
dc.date.available2020-09-23T12:35:05Z
dc.date.issued2020-05
dc.identifier.urihttps://repository.uneca.org/handle/10855/43788
uneca.workflow.processedtrue
uneca.language.supporteden
dc.format.extentxv, 51 p
dc.languageeng
dc.typePolicy paper
ags.creatorCorporateUnited Nations. Economic Commission for Africa
ags.subjectThesaurusPHARMACEUTICAL INDUSTRY
ags.subjectThesaurusPHARMACEUTICAL CHEMISTRY
ags.subjectThesaurusPHARMACEUTICALS
ags.subjectClassification05.04.00 CHEMICAL INDUSTRY AND PHARMACEUTICALS
ags.availabilityNumberb11985173
ags.availabilityLocationECA-HQ
ags.rights.termsofusepublic
ags.JNb11985173


Files in this item

Thumbnail

This item appears in the following Collection(s)